Medical Advances keeps track of new developments on the frontiers of medicine: The 1st founding anniversary of the Medical Advances

Medicine Advances is a platform dedicated to sharing cutting-edge research, insights, and advancements in the field of medicine. As the Editor-in-Chief, it is my privilege to guide this journal towards its mission of promoting knowledge, innovation, and excellence in healthcare. The aim of Medicine Advances is to provide a platform for researcher, scholars, and practitioners in healthcare to communicate and share their scientific findings and innovations. The journal is committed to promoting new medical theories, exchanging new clinical technologies, presenting new medical products, and accelerating the pace of medical development. This journal is dedicated to publishing high-quality original research articles, review articles, survey articles, case reports, editorials, and short communications. In 2023, we successfully launched the Medicine Advances and published 4 issues containing 37 high-quality articles. Among the published papers, the majority were original articles (19), accounting for 51%, followed by "review" and "case report" (8 and 2, respectively). Among these submissions, the proportion of Chinese authors is the highest (58%). But the manuscripts from India, Egypt, and the United States accounted for 32%. We have successfully established a WeChat public account in China, enhancing our accessibility and outreach. A total of 37 WeChat public account articles were published, and the articles and the journal received effective publicity. At the same time, we also promote on some international social media sites, like Twitter, Linkedin and ResearchGate. The continued publicity resulted in good downloads and citations. Our articles' readership and download rates have shown a consistent upward trend, which is a testament to our collective efforts. Together, these articles have amassed over 12,000 downloads and 5 citations. The involvement of 87 globally renowned experts in various medical specialties as our editorial members has significantly elevated our influence abroad. Seventeen of the 37 articles were from the journal's editorial board. The editorial board has made great contributions to the development of the journal. The enthusiastic reception of our special issues, "Application of Omics in Diseases" and "CardioRenal Research," inspires us to delve even deeper into these critical fields, evidence of our journal's synergy with the scientific community's pulse. The journal's progress has grown substantially since its inception. I would like to express my heartfelt gratitude to our authors, reviewers, and readers for their continuous support and dedication. Thank you for being a part of our journey. Your contributions are what make our journal thrive and evolve. Together, we can shape the future of medicine and healthcare, making a positive impact on the lives of millions. Xueqing Yu: Conceptualization; writing original draft; review; editing. None. The author declares no conflicts of interest. None. None. Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.